The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive care - 28/11/21
This article has been published in an issue click here to access
Highlight |
• | Patients with COVID-19 and neurological symptoms were extensively studied. |
• | The extent of brain MRI findings was quantified with a structured report. |
• | The report was created a priori, based on papers describing 197 patients with MRI. |
• | The score correlated with biomarkers, GCS, and number of days in intensive care. |
• | Correlation was strong with GFAp and t-tau in plasma - biomarkers for CNS damage. |
Abstract |
Background and purpose |
A wide range of neuroradiological findings has been reported in patients with coronavirus disease 2019 (COVID-19), ranging from subcortical white matter changes to infarcts, haemorrhages and focal contrast media enhancement. These have been descriptively but inconsistently reported and correlations with clinical findings and biomarkers have been difficult to extract from the literature. The purpose of this study was to quantify the extents of neuroradiological findings in a cohort of patients with COVID-19 and neurological symptoms, and to investigate correlations with clinical findings, duration of intensive care and biomarkers in blood.
Material and methods |
Patients with positive SARS-CoV-2 and at least one new-onset neurological symptom were included from April until July 2020. Nineteen patients were examined regarding clinical symptoms, biomarkers in blood and MRI of the brain. In order to quantify the MRI findings, a semi-quantitative neuroradiological severity scale was constructed a priori, and applied to the MR images by two specialists in neuroradiology.
Results and conclusions |
The score from the severity scale correlated significantly with blood biomarkers of CNS injury (glial fibrillary acidic protein, total-tau, ubiquitin carboxyl-terminal hydrolase L1) and inflammation (C-reactive protein), Glasgow Coma Scale score, and the number of days spent in intensive care. The underlying radiological assessments had inter-rater agreements of 90.5%/86% (for assessments with 2/3 alternatives). Total intraclass correlation was 0.80.
Previously reported neuroradiological findings in COVID-19 have been diverse and heterogenous. In this study, the extent of findings in MRI examination of the brain, quantified using a structured report, shows correlation with relevant biomarkers.
El texto completo de este artículo está disponible en PDF.Keywords : COVID-19, Neuroradiology, Biomarkers, MRI, Brain, Severity scale
Abbreviations : ADEM, COVID-19, CRP, GCS, GFAp, ICU, IL-6, Nerases, NfL, NIH, PCR, SARS-CoV-2, SWI, t-tau, UCHL1
Esquema
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.